A61K 31/28
Compounds containing heavy metals
A61K31/28 (Compounds containing heavy metals) appears on 1,988 US grants and 3,271 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,988
- Published applications
- 3,271
- Assignees
- 1,575
- Inventors
- 5,989
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 6 | 0 |
| 1979 | 7 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 8 | 0 |
| 1985 | 2 | 0 |
| 1986 | 11 | 0 |
| 1987 | 9 | 0 |
| 1988 | 6 | 0 |
| 1989 | 12 | 0 |
| 1990 | 19 | 0 |
| 1991 | 15 | 0 |
| 1992 | 18 | 0 |
| 1993 | 28 | 0 |
| 1994 | 14 | 0 |
| 1995 | 19 | 0 |
| 1996 | 20 | 0 |
| 1997 | 26 | 0 |
| 1998 | 39 | 0 |
| 1999 | 35 | 0 |
| 2000 | 44 | 0 |
| 2001 | 44 | 17 |
| 2002 | 50 | 50 |
| 2003 | 30 | 86 |
| 2004 | 30 | 123 |
| 2005 | 32 | 110 |
| 2006 | 28 | 118 |
| 2007 | 24 | 126 |
| 2008 | 27 | 108 |
| 2009 | 26 | 116 |
| 2010 | 37 | 115 |
| 2011 | 67 | 103 |
| 2012 | 51 | 94 |
| 2013 | 63 | 150 |
| 2014 | 82 | 175 |
| 2015 | 103 | 156 |
| 2016 | 112 | 147 |
| 2017 | 102 | 167 |
| 2018 | 87 | 157 |
| 2019 | 105 | 176 |
| 2020 | 104 | 154 |
| 2021 | 91 | 185 |
| 2022 | 83 | 162 |
| 2023 | 55 | 113 |
| 2024 | 76 | 164 |
| 2025 | 81 | 107 |
| 2026 | 42 | 92 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Imidazole-based synthetic lipidoids for in vivo mRNA delivery into immune cells29 Sep 2026US 12,747,214 B2Trustees of Tufts College
- Use of an organometallic compound as a DNA-demethylating agent22 Sep 2026US 12,740,961 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Cobalt-porphyrin complexes for the inactivation of the biological activity of opioids15 Sep 2026US 12,734,146 B2The Government of the United States of America, as represented by the Secretary of the Navy
- Methods of treating breast cancer15 Sep 2026US 12,738,355 B2City of Hope
- Systems and methods for transderman patch delivery8 Oct 2026US 2026/0306421 A1
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306457 A1Geneiii Biotech Company Ltd.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof8 Oct 2026US 2026/0306471 A1Insilico Medicine IP Limited
- Treatment of cancer with a combination of an antibody that binds egfr and cytotoxic drugs1 Oct 2026US 2026/0295040 A1Merus N.V.
Most cited
By later US patents
- Treatment of female sexual dysfunction239US 5,877,216 AVivus, Inc. · 1999
- Treatment of female sexual dysfunction233US 6,294,550 B1Asivi, LLC · 2001
- Treatment of female sexual dysfunction212US 6,306,841 B1Asivi, LLC · 2001
- Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors183US 6,133,320 ABoard of Regents, The University of Texas System · 2000
- Sexual lubricants containing zinc as an anti-viral agent173US 5,208,031 A1993